全文获取类型
收费全文 | 1868篇 |
免费 | 130篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 88篇 |
妇产科学 | 87篇 |
基础医学 | 193篇 |
口腔科学 | 67篇 |
临床医学 | 194篇 |
内科学 | 412篇 |
皮肤病学 | 19篇 |
神经病学 | 94篇 |
特种医学 | 55篇 |
外科学 | 317篇 |
综合类 | 38篇 |
预防医学 | 72篇 |
眼科学 | 68篇 |
药学 | 128篇 |
中国医学 | 7篇 |
肿瘤学 | 161篇 |
出版年
2024年 | 2篇 |
2023年 | 9篇 |
2022年 | 16篇 |
2021年 | 36篇 |
2020年 | 23篇 |
2019年 | 42篇 |
2018年 | 43篇 |
2017年 | 33篇 |
2016年 | 41篇 |
2015年 | 52篇 |
2014年 | 52篇 |
2013年 | 80篇 |
2012年 | 106篇 |
2011年 | 134篇 |
2010年 | 91篇 |
2009年 | 81篇 |
2008年 | 120篇 |
2007年 | 100篇 |
2006年 | 92篇 |
2005年 | 119篇 |
2004年 | 106篇 |
2003年 | 87篇 |
2002年 | 80篇 |
2001年 | 59篇 |
2000年 | 68篇 |
1999年 | 49篇 |
1998年 | 25篇 |
1997年 | 20篇 |
1996年 | 20篇 |
1995年 | 17篇 |
1994年 | 31篇 |
1993年 | 19篇 |
1992年 | 27篇 |
1991年 | 22篇 |
1990年 | 25篇 |
1989年 | 29篇 |
1988年 | 11篇 |
1987年 | 10篇 |
1986年 | 6篇 |
1985年 | 7篇 |
1984年 | 7篇 |
1983年 | 4篇 |
1980年 | 4篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1976年 | 5篇 |
1975年 | 2篇 |
1972年 | 3篇 |
1962年 | 1篇 |
1875年 | 1篇 |
排序方式: 共有2026条查询结果,搜索用时 15 毫秒
31.
Characteristics and trends in incidence of inflammatory bowel disease in Taiwanese children. 总被引:1,自引:0,他引:1
Cheng-Hsien Tsai Huey-Ling Chen Yen-Hsuan Ni Hong-Yuan Hsu Yung-Ming Jeng Chi-Jeng Chang Mei-Hwei Chang 《台湾医志》2004,103(9):685-691
BACKGROUND AND PURPOSE: Although chronic inflammatory bowel disease (IBD) is rare in Asian children, increasing numbers of pediatric patients with chronic IBD worldwide have been noted in recent years. This study was conducted to delineate the trend in incidence and clinical patterns of childhood IBD in Taiwan. METHODS: All children admitted to National Taiwan University Hospital (NTUH) between 1979 and 2000 who met the criteria for IBD, Crohn's disease (CD), ulcerative colitis (UC), probable CD (PCD), or indeterminate colitis were included. The clinical features and outcomes were analyzed retrospectively. Incidence was calculated using cases of chronic diarrhea during the same period of time as the risk population. RESULTS: IBD was diagnosed in 17 children (9 females and 8 males, aged 2 months to 18 years) during the study period. Six (35%) of these children had UC, 9 (53%) had CD, and 2 (12%) had PCD. The cumulative incidence of CD during 1979-1995 was 0.85%, and increased to 2.6% during 1996-2000 (p < 0.001), while the incidence of UC did not change significantly between these periods (from 0.85% to 0.99%, p = 0.16). The median interval from onset to diagnosis was 7.7 months. Eighty percent of patients had moderate to severe disease activity at diagnosis. The follow-up duration ranged from less than 1 year to 20 years, with a mean of 4.3 years. Two patients were lost to follow-up. Eighty six percent of patients responded to treatment, and 80% of patients had inactive to mild disease activity when re-evaluated at the end of 2000. CONCLUSION: There has been a marked recent increase in the incidence of childhood CD in Taiwan but the rate of childhood UC has remained unchanged. Eighty percent of cases of childhood IBD responded well to treatment. 相似文献
32.
Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection? 总被引:13,自引:0,他引:13
HYPOTHESIS: Mutant p53 gene has lost its tumor suppression function and is considered to be a very important step in hepatocellular carcinoma development. We propose that the mutant p53 gene plays a role in its invasiveness and prognosis after resection. DESIGN: A case-controlled study. SETTING: A referral center. PATIENTS: Seventy-nine consecutive patients who underwent surgical resection for hepatocellular carcinoma entered this study. INTERVENTION: Tissue sections of resected hepatocellular carcinoma (deparaffinized and rehydrated from formalin-fixed and paraffin-embedded sections) were incubated with antihuman p53 monoclonal antibody and immunostained. The p53 result was scored without prior knowledge of the patients' status. A 10% immunopositivity was regarded as the threshold value. MAIN OUTCOME MEASURE: The immunopositive rate of p53 was 69.6% (55 of 79 patients). The clinical variables (age, sex, associated liver cirrhosis, hepatitis B virus infection, hepatitis C virus infection, serum alpha-fetoprotein, and Child-Pugh class); the histological variables (size, capsule, vascular permeation; grade of differentiation, and multinodularity); and postoperative course (recurrence, tumor-free interval, death, and survival period) were correlated with p53 immunopositivity. RESULTS: From univariate analysis, more patients with p53 positivity were male (92.7 vs 0%) (P<.001); had vascular permeation (80% vs 50%) (P =.007) (odds ratio [OR], 4.0); no complete capsule (83.6% vs 62.5%) (P =.04) (OR, 3.1); and daughter nodules (90.9% vs 70.8%) (P =.04) (OR, 4.1) than patients with negative p53 staining. From multivariate analysis, only sex and vascular permeation remained significant (P =.001 and P =.008, respectively). Although more patients with p53 positivity had tumor recurrence (78% vs 50%) (P =.01) and death (64% vs 33%) (P =. 01), the Cox proportional hazards model showed that p53 overexpression had only weak correlations with tumor-free interval and survival time (P =.09 and P =.08, respectively). CONCLUSIONS: Our results show that the biological behavior of the mutant p53 gene is strongly related to the invasiveness of hepatocellular carcinoma and may also influence the postoperative course. We suggest that the immunopositivity of the mutant p53 gene has a predictive role in the prognosis of patients with resected hepatocellular carcinoma. 相似文献
33.
Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway. 总被引:4,自引:0,他引:4
Ming-Tsai Lin Chung-Yaou Zuon Cheng-Chi Chang Szu-Ta Chen Chih-Ping Chen Been-Ren Lin Ming-Yang Wang Yung-Ming Jeng King-Jen Chang Po-Huang Lee Wei-Jao Chen Min-Liang Kuo 《Clinical cancer research》2005,11(16):5809-5820
PURPOSE: Cysteine-rich 61 (Cyr61/CCN1) is involved in many different types of tumor development and progression. Nonetheless, the role of Cyr61 in human gastric cancer has not yet been fully characterized.Experimental design: We addressed the issue by immunohistochemical staining of 81 gastric adenocarcinoma specimens. Liposome-mediated transfection was used to introduce a Cyr61 expression vector into gastric cancer AGS cell lines. Transfectants were tested in invasion assay by a Boyden chamber. Furthermore, a cyclooxygenase-2 (COX-2) reporter assay and gel mobility shift assay were done to investigate the potential signal pathway of Cyr61. RESULTS: Patients with gastric adenocarcinoma whose tumor displayed high expression of Cyr61 correlated well with aggressive lymph node metastasis, more advanced tumor stage, histologic diffuse type, and early recurrence. Stable transfection of Cyr61 into the AGS cell line strongly enhanced its invasive activity. The overexpression of Cyr61 into AGS cells significantly increased the expression of COX-2 mRNA, protein, and enzymatic activity. Gel mobility shift assays further showed that the nuclear factor-kappaB (NF-kappaB) pathway was evidently activated in Cyr61-expressing AGS cells. Function-neutralizing antibody to alphavbeta3 but not alphavbeta5 effectively suppressed Cyr61-mediated NF-kappaB activation, COX-2 gene expression, and cell invasiveness. CONCLUSIONS: Cyr61 may contribute to the malignant progression of gastric cancer by promoting tumor cell motility/invasion through up-regulation of the functional COX-2 via an integrin alphavbeta3/NF-kappaB-dependent pathway. 相似文献
34.
Maneesha Bhaya M.D. Ferit Onur Mutluer M.D. Edward Mahan M.D. Luke Mahan Ming C. Hsiung M.D. Wei–Hsian Yin M.D. Ph.D. Jeng Wei M.D. MsD Shen–Kou Tsai M.D. Ph.D. Guang–Yu Zhao M.D. Wei–Hsian Yin M.D. Manish Pradhan M.D. Rajesh Beniwal M.D. Deepak Joshi M.D. Fatemeh Nabavizadeh M.D. Amitoj Singh M.B.B.S. Navin C. Nanda M.D. 《Echocardiography (Mount Kisco, N.Y.)》2013,30(3):345-353
35.
Jia‐Huei Tsai Wen‐Chih Huang Kuan‐Ting Kuo Ray‐Hwang Yuan Yu‐Ling Chen Yung‐Ming Jeng 《Histopathology》2012,61(6):1106-1116
Tsai J‐H, Huang W‐C, Kuo K‐T, Yuan R‐H, Chen Y‐L & Jeng Y‐M (2012) Histopathology S100P immunostaining identifies a subset of peripheral‐type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas Aims: S100P is a calcium‐binding protein that is frequently expressed in pancreatic adenocarcinoma and perihilar cholangiocarcinoma. The aim of this study was to investigate the pathological significance of the expression of S100P in peripheral intrahepatic cholangiocarcinoma (ICC). Methods and results: Immunohistochemical staining was used to investigate S100P expression in 112 cases of peripheral ICC. The results were compared with those for perihilar and extrahepatic cholangiocarcinomas. Patients with S100P‐positive peripheral ICC were more likely to have elevated serum levels of carcinoembryonic antigen (CEA) and CA19‐9 than those with S100P‐negative peripheral ICCs. All cases of peripheral ICC associated with intrahepatic lithiasis and all cases with intraductal/periductal growth patterns were positive for S100P. S100P‐positive peripheral ICCs were highly associated with ‘bile duct’ morphology rather than cholangiolar differentiation. Nearly all cases of perihilar and extrahepatic cholangiocarcinoma were positive for S100P. Similarly to perihilar and extrahepatic cholangiocarcinomas, S100P‐positive peripheral ICCs showed more frequent expression of CEA and MUC2, and were more likely to be N‐cadherin‐negative, than S100P‐negative cases. Notably, K‐RAS mutations were only detected in S100P‐positive peripheral ICCs, with a frequency similar to that in perihilar and extrahepatic cholangiocarcinomas. Patients with S100P‐positive peripheral ICC were more likely to have poor prognoses than those with S100P‐negative tumours. Conclusions: S100P immunostaining identifies a subset of peripheral ICC that probably originates from larger bile ducts. This subset of peripheral ICCs shares common morphological and molecular features with perihilar and extrahepatic cholangiocarcinomas. 相似文献
36.
37.
38.
39.
40.